When was Abzena founded?

Abzena was founded in 2001 and raised its 1st funding round 6 years after it was founded.

Where is Abzena located?

Abzena is headquartered in Cambridge, United Kingdom. It is registered at Babraham Research Campus, Babraham Cambridge CB22 3AT UK.

How many employees does Abzena have?

As of May 31, 2026, the latest employee count at Abzena is 434.

Is Abzena a funded company?

Abzena is a funded company, having raised a total of $67.1M across 11 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jun 20, 2007.

When was the latest funding round of Abzena?

Abzena's latest funding was a $***** Post IPO round on Mar 31, 2022, with participation from 2 investors. Its primary sector is Biopharma Outsourcing. In United Kingdom, the Biopharma Outsourcing sector has seen $34M in funding in 2026 to date.

Where does Abzena rank among its competitors?

Abzena ranks 5th amongst 320 active competitors, of which 20 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of Abzena?

Abzena's top competitors include Anthem Biosciences, Patheon and KBI Biopharma. Among them, Abingdon Health secured the most recent funding round in October, 2025.

Abzena - 2026 Company Profile, Team, Funding, Competitors & Financials

Abzena is an acquired company based in Cambridge (United Kingdom), founded in 2001. It operates as a Provider of antibody discovery, cell line development, and bio analytics services. Abzena has raised $67.1M in funding from investors like Imperial Innovations, Invesco Perpetual and Mercia. The company has 320 active competitors, including 20 funded and 98 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and KBI Biopharma.

Company Details

Provider of antibody discovery, cell line development, and bio analytics services. The company mainly provides proprietary technologies, mammalian and bio conjugates manufacturing, peptide synthesis, analytical development, cell line development, and bio assays services.

Website: abzena.com
Social
Email ID: *****@abzena.com
Phone Number: +44 **********
Registered Address: Babraham Research Campus, Babraham Cambridge CB22 3AT UK

Key Metrics

Founded Year

2001

Location

Cambridge, United Kingdom

Stage

Acquired

Total Funding

$67.1M in 11 rounds

Latest Funding Round

Post IPO, Mar 31, 2022, $*****

Investors

Imperial Innovations & 12 more

Ranked

5^th among 320 active competitors

Employee Count

434 as on May 31, 2026

Similar Companies

Anthem Biosciences & 208 more

Exit Details

Acquired by Welsh, Carson, Anderson & Stowe (Aug 16, 2018)

View Abzena's full profile

Abzena is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
ABZENA, INC. CIN: 73-1731905 , United States, Active	Jul 20, 2015	-	217 (As on Dec 31, 2020)	-
ABZENA LIMITED CIN: 8957107 , United Kingdom, Active	Mar 24, 2014	-	89 (As on Dec 31, 2020)

Abzena got acquired by Welsh, Carson, Anderson & Stowe on Aug 16, 2018 at an acquisition amount of $*****.

Click here to take a look at Abzena's acquisition in detail

Abzena has raised a total funding of $67.1M over 11 rounds. Its first funding round was on Jun 20, 2007. Its latest funding round was a Post IPO round on Mar 31, 2022 for $*****. 2 investors participated in its latest round. Abzena has 13 institutional investors.

Here is the list of recent funding rounds of Abzena:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 31, 2022	5057271	Post IPO	4372137	7923712	1575220	2567521
Jul 28, 2020	4200776	Post IPO	9325298	7842327	7321244	Biospring Partners
Apr 21, 2017	3438425	Post IPO	8962859	3707521	6022600	Touchstone Innovations

Access funding benchmarks and valuations. Sign up today!

View details of Abzena's funding rounds and investors

Abzena's employee count trend

Abzena has 434 employees as of May 26. Here is Abzena's employee count trend over the years:

Uncover Abzena's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Abzena include Anthem Biosciences, Patheon and KBI Biopharma. Here is the list of Top 10 competitors of Abzena, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	77/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	JLL Partners, Frazier Healthcare Partners ... & 3 others	75/100
3rd	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	68/100
4th	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	66/100
5th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	YFM Equity Partners, Welsh, Carson, Anderson & Stowe ... & 11 others	66/100
6th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 2 others	64/100
7th	Panacea Biotec 1984, Ambala (India), Public	Developer of biosimilars, vaccines and natural products	-	India Resurgence Fund, Department of Biotechnology ... & 1 others	62/100
8th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
9th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
10th	Piramal Pharma Solutions 1988, Mumbai (India), Unfunded	Contract manufacturer of pharmaceutical products	-	Thecarlylegroup.fr	57/100